Jakafi 15 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FTA18
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,508
Award facts
- Contract value 100% obligated
- $36,508.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 28, 2025, valued at $36.5K. The order is for 60 tablets of Jakafi 15 mg, a prescription medication used to treat certain blood disorders and conditions. This delivery order, with a completion date of September 29, 2025, was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal marketplace based on its established capabilities and small business status. The place of performance is the company's facility in Park Ridge, Illinois.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.999B and valid through November 2026. The IDC serves as the primary vehicle enabling the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently demonstrated its capacity to deliver specialized medical products to military health facilities, with this delivery order representing one of numerous pharmaceutical procurements under the umbrella contract.
Quick answers
Who was awarded contract SPE2DB25FTA18?
SPE2DB25FTA18 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 28, 2025.
How much is contract SPE2DB25FTA18 worth?
The government has obligated $36,508 on SPE2DB25FTA18.
Is contract SPE2DB25FTA18 an order under another contract?
Yes. SPE2DB25FTA18 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FTA18 competed?
The extent of competition for SPE2DB25FTA18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award